Temocillin use as a carbapenem-sparing option in a UK teaching hospital for treating serious Gram-negative bacterial infections

Detalles Bibliográficos
Autores principales: Enoch, D A, Murphy, M E, Gouliouris, T, Santos, R, Micallef, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619245/
https://www.ncbi.nlm.nih.gov/pubmed/36324332
http://dx.doi.org/10.1093/jacamr/dlac111
_version_ 1784821233462804480
author Enoch, D A
Murphy, M E
Gouliouris, T
Santos, R
Micallef, C
author_facet Enoch, D A
Murphy, M E
Gouliouris, T
Santos, R
Micallef, C
author_sort Enoch, D A
collection PubMed
description
format Online
Article
Text
id pubmed-9619245
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96192452022-11-01 Temocillin use as a carbapenem-sparing option in a UK teaching hospital for treating serious Gram-negative bacterial infections Enoch, D A Murphy, M E Gouliouris, T Santos, R Micallef, C JAC Antimicrob Resist Correspondence Oxford University Press 2022-10-31 /pmc/articles/PMC9619245/ /pubmed/36324332 http://dx.doi.org/10.1093/jacamr/dlac111 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Enoch, D A
Murphy, M E
Gouliouris, T
Santos, R
Micallef, C
Temocillin use as a carbapenem-sparing option in a UK teaching hospital for treating serious Gram-negative bacterial infections
title Temocillin use as a carbapenem-sparing option in a UK teaching hospital for treating serious Gram-negative bacterial infections
title_full Temocillin use as a carbapenem-sparing option in a UK teaching hospital for treating serious Gram-negative bacterial infections
title_fullStr Temocillin use as a carbapenem-sparing option in a UK teaching hospital for treating serious Gram-negative bacterial infections
title_full_unstemmed Temocillin use as a carbapenem-sparing option in a UK teaching hospital for treating serious Gram-negative bacterial infections
title_short Temocillin use as a carbapenem-sparing option in a UK teaching hospital for treating serious Gram-negative bacterial infections
title_sort temocillin use as a carbapenem-sparing option in a uk teaching hospital for treating serious gram-negative bacterial infections
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619245/
https://www.ncbi.nlm.nih.gov/pubmed/36324332
http://dx.doi.org/10.1093/jacamr/dlac111
work_keys_str_mv AT enochda temocillinuseasacarbapenemsparingoptioninaukteachinghospitalfortreatingseriousgramnegativebacterialinfections
AT murphyme temocillinuseasacarbapenemsparingoptioninaukteachinghospitalfortreatingseriousgramnegativebacterialinfections
AT gouliourist temocillinuseasacarbapenemsparingoptioninaukteachinghospitalfortreatingseriousgramnegativebacterialinfections
AT santosr temocillinuseasacarbapenemsparingoptioninaukteachinghospitalfortreatingseriousgramnegativebacterialinfections
AT micallefc temocillinuseasacarbapenemsparingoptioninaukteachinghospitalfortreatingseriousgramnegativebacterialinfections

Ejemplares similares